Indication
Bacterial skin and skin structure infection
A bacterial skin and skin structure infection is a microbial invasion affecting the epidermis, dermis, subcutaneous tissues, or deeper soft-tissue structures. Read more about Bacterial skin and skin structure infection
28 drugs 14 manufacturers
Drugs that treat it
Common Bacterial skin and skin structure infection therapies.
GENTAMICIN SULFATE
GENTAMICIN SULFATE
GENTAMICIN SULFATE
NUZYRA (omadacycline tosylate)
NUZYRA (omadacycline tosylate)
NUZYRA (omadacycline tosylate)
NUZYRA (omadacycline tosylate)
GENTAMICIN (gentamicin sulfate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA bacterial skin and skin structure infection is a microbial invasion affecting the epidermis, dermis, subcutaneous tissues, or deeper soft-tissue structures.
Occurring across pediatric and adult populations, these infections commonly manifest as cellulitis, erysipelas, cutaneous abscesses, or wound infections.
They are predominantly driven by Gram-positive pathogens, notably *Staphylococcus aureus*—including methicillin-resistant strains—and *Streptococcus pyogenes*, with Gram-negative or anaerobic organisms occasionally implicated in deeper or compromised sites.
Pathophysiologically, pathogen entry through a disrupted epithelial barrier triggers localized tissue inflammation, induration, erythema, edema, warmth, and pain, occasionally progressing to purulent drainage, tissue necrosis, or systemic inflammatory response.
- nih.gov
A bacterial skin and skin structure infection is a microbial invasion affecting the epidermis, dermis, subcutaneous tissues, or deeper soft-tissue structures They are predominantly driven by Gram-positive pathogens, notably *Staphylococcus aureus*—including methicillin-resistant strains—and *Streptococcus pyogenes*, with Gram-negative or anaerobic organisms occasionally implicated in deeper or compromised sites
- nih.gov
A bacterial skin and skin structure infection is a microbial invasion affecting the epidermis, dermis, subcutaneous tissues, or deeper soft-tissue structures Pathophysiologically, pathogen entry through a disrupted epithelial barrier triggers localized tissue inflammation, induration, erythema, edema, warmth, and pain, occasionally progressing to purulent drainage, tissue necrosis, or systemic inflammatory response
- fda.gov
Occurring across pediatric and adult populations, these infections commonly manifest as cellulitis, erysipelas, cutaneous abscesses, or wound infections They are predominantly driven by Gram-positive pathogens, notably *Staphylococcus aureus*—including methicillin-resistant strains—and *Streptococcus pyogenes*, with Gram-negative or anaerobic organisms occasionally implicated in deeper or compromised sites Pathophysiologically, pathogen entry through a disrupted epithelial barrier triggers local...
- merckmanuals.com
Occurring across pediatric and adult populations, these infections commonly manifest as cellulitis, erysipelas, cutaneous abscesses, or wound infections
Personalize your experience
Follow Bacterial skin and skin structure infection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.